Youth-HIV activist, Shamin Mohamed Jr., celebrates 15 years of LetsStopAIDS on World AIDS Day
29 nov. 2019 07h00 HE
|
LetsStopAIDS
TORONTO, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Canadian HIV-activist Shamin Mohamed Jr. founded LetsStopAIDS at 15 years old, a youth-driven HIV charity celebrating its 15th Anniversary on World AIDS...
bioLytical Laboratories Named B.C. Exporter of the Year
26 nov. 2019 09h00 HE
|
bioLytical Laboratories Inc.
Award recognizes bioLytical as “the best of the best” for its achievements as an export company, and its contribution to the B.C. economy RICHMOND, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE)...
INSTI now available for expanded point-of-care use in Canada
19 sept. 2019 09h00 HE
|
bioLytical Laboratories Inc.
RICHMOND, British Columbia, Sept. 19, 2019 (GLOBE NEWSWIRE) -- bioLytical Laboratories, a world leader in rapid diagnostic tests for infectious diseases, is pleased to announce that the INSTI HIV-1...
New Report From Grantmakers In Aging Explores Experiences and Unique and Unmet Needs of Older People Living With HIV/AIDS
12 sept. 2019 16h31 HE
|
Grantmakers In Aging
WASHINGTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- For years, it seemed unlikely that most people living with HIV or AIDS would live long lives, but much has changed and HIV/AIDS must now be regarded as...
Intravenous Immunoglobulin (IVIG) Market To Reach USD 15.67 Billion By 2026 | Reports And Data
28 mai 2019 12h38 HE
|
Reports And Data
The rapid increase in neurological disorders, increase in geriatric population, and continuous increase in the number of patients are fueling the market growth. Market Size – USD 9.43 Billion in...
GeoVax Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress
14 mai 2019 10h23 HE
|
GeoVax, Inc.
ATLANTA, May 14, 2019 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
GeoVax Announces Reverse Stock Split
03 mai 2019 08h59 HE
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
AXIM® Biotech Enters Services Agreement With CRO to Begin Clinical Studies On Dronabinol and CBD Chewing Gums
09 avr. 2019 09h35 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today...
GeoVax Provides Product Development and Corporate Update
11 mars 2019 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...
GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message
06 févr. 2019 10h11 HE
|
GeoVax, Inc.
Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development ATLANTA, GA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX)....